Table 3.
Body composition groups based on sex-specific values, creeping fat, and occurrence of complicated disease (n = 114)
Groups | Patients with inflammatory disease, total (n = 54), n (%) | Patients with Complicated disease total (n = 60), n (%) | p value |
---|---|---|---|
Low/normal SATI | 31 (27.2) | 28 (24.6) | 0.25 |
High SATI | 23 (20.2) | 32 (28.1) | |
Low/normal VATI | 44 (38.6) | 48 (42.1) | 0.84 |
High VATI | 10 (8.8) | 12 (10.5) | |
Low/normal VAT/SAT ratio | 37 (32.5) | 38 (33.3) | 0.56 |
High VAT/SAT ratio | 17(14.9) | 22 (19.3) | |
Non-sarcopenic | 20 (17.5) | 26 (22.8) | 0.50 |
Sarcopenic | 34 (29.8) | 34 (29.8) | |
CrF absent | 44 (38.5) | 41 (35.9) | 0.11 |
CrF present | 10 (8.7) | 19 (16.6) |
SATI, subcutaneous adipose tissue index; VATI, visceral adipose tissue index; VAT/SAT ratio, visceral-to-subcutaneous fat ratio; CrF, creeping fat.